The efficacy and safety of systemic injection of Ginkgo biloba extract, EGb761, in idiopathic sudden sensorineural hearing loss: a randomized placebo-controlled clinical trial

Trial Profile

The efficacy and safety of systemic injection of Ginkgo biloba extract, EGb761, in idiopathic sudden sensorineural hearing loss: a randomized placebo-controlled clinical trial

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Mar 2017

At a glance

  • Drugs EGb 761 (Primary) ; Methylprednisolone
  • Indications Sudden hearing loss
  • Focus Therapeutic Use
  • Acronyms YY_TNI_2011
  • Sponsors Yuyu
  • Most Recent Events

    • 07 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top